Opinion statement Early secondary prevention trials of fish and omega-3 polyunsaturated
fatty acid (PUFA) capsules reported beneficial effects on cardiovascular disease (CVD) …

Omega-3 polyunsaturated fatty acid (ω-3 PUFA) therapy continues to show great promise in
primary and, particularly in secondary prevention of cardiovascular (CV) diseases. The most …

Introduction: An epidemiological study of Greenlandic Inuit suggested the importance of
omega-3 polyunsaturated fatty acids (PUFAs) in preventing ischemic heart disease. After …

The recent publication of the REDUCE-IT study has reopened the debate about the efficacy
of omega-3 fatty acids in reducing the risk of cardiovascular (CV) events. This meta-analysis …

Context Considerable controversy exists regarding the association of omega-3
polyunsaturated fatty acids (PUFAs) and major cardiovascular end points. Objective To …

Introduction: Large-scale epidemiological studies on Greenlandic, Canadian and Alaskan
Eskimos have examined the health benefits of omega-3 fatty acids consumed as part of the …

Omega-3 polyunsaturated fatty acids (PUFAs) are a key component of a heart-healthy diet.
For patients without clinical atherosclerotic cardiovascular disease, 2 or more servings of …

We reviewed available evidence for cardiovascular effects of n-3 polyunsaturated fatty acid
(PUFA) consumption, focusing on long chain (seafood) n-3 PUFA, including their principal …

Almost forty years ago, it was first hypothesized that an increased dietary intake of omega‐3
polyunsaturated fatty acids (PUFA) from fish fat could exert protective effects against several …

Multiple randomized controlled trials (RCTs) have assessed the effects of supplementation
with eicosapentaenoic acid plus docosahexaenoic acid (omega-3 polyunsaturated fatty …